KVAC
Finance · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
37 Greenbriar Dr, Summit, New Jersey, 07...Phone Number
(203) 609-1394Website
www.kv-ac.comRevenue
<$5 MillionStock Symbol
KVACIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About KVAC
KVAC is a newly organized blank check company incorporated in the British Virgin Islands as a business company with limited liability for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities (the target).Explore more
Popular SearchesKeen Vision Acquisition CorpSIC Code 67,679NAICS Code 52,523Ticker ASX: KVACShow moreKVAC Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is KVAC your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if KVAC had a recent Job posting/layoffs
Product Launch: Get notified when KVAC launches new products
KVAC, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if KVAC is spiking on competitors!
Check if KVAC has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at KVAC
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on KVAC recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once KVAC has new funding data
Recommended Actions
Reach out to Masked Content who joined KVAC as Masked Content
Find 2 more new buyers
Compare Similar Companies to KVAC
Compare insights from companies similar to KVAC, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
KVAC is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
KVAC is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about KVAC.
KVAC Tech Stack
A closer look at the technologies used by KVAC
KVAC News & Media
Medera’s Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart Syndrome
BOSTON and SAN DIEGO and ROCHESTER, Minn., June 24, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing a range of next-generation therapeutics, and Novoheart, its wholly owned pre-clinical subsidiary pioneering human-based cardiac tissue engineering for disease modelling and drug screening, today announced a groundbreaking collaboration with physician-scientists at the University of California SanMedera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025
BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing a range of next-generation therapeutics, and Novoheart, its wholly owned pre-clinical subsidiary pioneering human-based cardiac tissue engineering for disease modelling and drug screening, today announced the successful presentation of seven scientific abstracts at the 2025 International Society for Stem Cell Research (ISSCR) AnnuMedera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 Congress
BOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing a range of next-generation therapeutics, today announced that positive interim data from its ongoing MUSIC-HFpEF Phase 1/2a clinical trial was presented at the Heart Failure 2025 Congress taking place in Belgrade, Serbia. The late-breaking presentation, titled "Gene therapy for heart failure with preserved ejection fraction," was dMedera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 Congress
BOSTON, May 12, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing a range of next-generation therapeutics, today announced that data from its First-In-Human Phase 1/2a MUSIC-HFpEF clinical trial investigating its adeno-associated virus-based gene therapy candidate SRD-002 in heart failure with preserved ejection fraction (HFpEF) will be presented at the upcoming Heart Failure 2025 Congress taking
Read more news
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding KVAC
Sign Up For FreeTo access detailed company insights
KVAC is a newly organized blank check company incorporated in the British Virgin Islands as a business company with limited liability for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities (the target).... Read More
